Details
Stereochemistry | RACEMIC |
Molecular Formula | 2C16H26N2O4.H2O4S |
Molecular Weight | 718.856 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.COC(=O)NCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COC(=O)NCCC2=CC=C(OCC(O)CNC(C)C)C=C2
InChI
InChIKey=OUXGIOLQOYAZLS-UHFFFAOYSA-N
InChI=1S/2C16H26N2O4.H2O4S/c2*1-12(2)18-10-14(19)11-22-15-6-4-13(5-7-15)8-9-17-16(20)21-3;1-5(2,3)4/h2*4-7,12,14,18-19H,8-11H2,1-3H3,(H,17,20);(H2,1,2,3,4)
Molecular Formula | C16H26N2O4 |
Molecular Weight | 310.3886 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28193 |
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28193 |
Pamatolol is a beta-Adrenergic receptor antagonist was studied as an Antiarrhythmic agent. The phase I clinical trial has shown that the drug was relatively cardioselective in man. Information about the further development of this drug is not available.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol. | 1979 |
|
Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker. | 1979 Dec |
|
Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. | 1985 Mar |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/40725
Minor reductions in standing and exercise and isoproterenol-induced increases in heart rate were observed with the 10-mg oral dose and appeared maximal with the 400-600 mg dose.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:27:15 GMT 2023
by
admin
on
Fri Dec 15 17:27:15 GMT 2023
|
Record UNII |
1RT2DU4P6T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1RT2DU4P6T
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY | |||
|
C166513
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY | |||
|
43149
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110710
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY | |||
|
DTXSID70975377
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY | |||
|
59954-01-7
Created by
admin on Fri Dec 15 17:27:15 GMT 2023 , Edited by admin on Fri Dec 15 17:27:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |